Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/MoonLake Immunotherapeutics/ S-3ASR

SEC Filing · S-3ASR

MoonLake Immunotherapeutics

MLTXNASDAQEQUITYCurrent

SEC Filing

Filed Aug 10, 2026Accepted Aug 10, 2026, 4:37 PM EDTCIK 1821586Accession 0001213900-26-087295
View company →Permanent SEC source ↗
Share

Company context

Current securities

MLTXNASDAQ · EQUITY · Current
Historical securities (1)
HLXANASDAQ · EQUITY · Historical · closed Apr 6, 2022

Recent company filings

  1. SCHEDULE 13G filingAug 14, 2026
  2. SCHEDULE 13G/A filingAug 14, 2026
  3. S-8 filingAug 10, 2026
  4. 10-Q filingAug 10, 2026
  5. Results of Operations and Financial Condition · Regulation FD DisclosureAug 10, 2026

As-filed source

Primary evidence
As filedOpen full document ↗